Immune thrombocytopenic purpura healing after removing cardiac thrombosis

Omer Topaloglu 1, Ali Akdogan 2 * , Ahmet Coskun Ozdemir 1
More Detail
1 Department of Cardiovascular Surgery, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
2 Department of Anaesthesiology and Intensive Care, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
* Corresponding Author
J CLIN MED KAZ, Volume 19, Issue 5, pp. 48-50. https://doi.org/10.23950/jcmk/12506
OPEN ACCESS 840 Views 635 Downloads
Download Full Text (PDF)

ABSTRACT

Because of the rareness of the reports about immune thrombocytopenic purpura patients undergoing cardiac surgery, there is no sufficient knowledge about perioperative strategies. In this article, we report a 42-year-old female patient with severe mitral regurgitation and large right atrial thrombus, in whom thrombocytopenia had disappeared after mitral valve replacement and thrombectomy from the right atrium. Large thrombi should kept in mind as reason of thrombocytopenia.
Keywords: open heart surgery, immune thrombocytopenic purpura, thrombocytopenia, cardiac thrombus

CITATION

Topaloglu O, Akdogan A, Ozdemir AC. Immune thrombocytopenic purpura healing after removing cardiac thrombosis. J CLIN MED KAZ. 2022;19(5):48-50. https://doi.org/10.23950/jcmk/12506

REFERENCES

  • Abrahamson PE, Hall SA, Feudjo-Tepie M, Mitrani-Gold FS, Logie J. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol. 2009;83(2):83-9. https://doi.org/10.1111/j.1600-0609.2009.01247.x
  • Köner O, Cetin G, Karaoğlu K, Seren S, Bakay C. Fresh whole blood and immunoglobulin permit coronary artery bypass graft surgery in patients with idiopathic thrombocytopenic purpura. J Cardiothorac Vasc Anesth. 2001;15(4):483-4. https://doi.org/10.1053/jcan.2001.25001
  • Christiansen S, Schmid C, Redmann K, Jahn UR, Stypmann J, Scheld HH, et al. Preoperative immunoglobulin treatment in patients with Werlhof's disease undergoing cardiac operation. Ann Thorac Surg. 2000;69(1):61-4. https://doi.org/10.1016/s0003-4975(99)01158-3
  • Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-3817. https://doi.org/10.1182/bloodadvances.2019000812
  • Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J; ITP Study Group. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol. 2004;76(3):205-13. https://doi.org/10.1002/ajh.20104
  • Diz-Küçükkaya R, Hacihanefioğlu A, Yenerel M, Turgut M, Keskin H, Nalçaci M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood. 2001;98(6):1760-4. https://doi.org/10.1182/blood.v98.6.1760
  • Kitchens CS. Thrombocytopenia due to acute venous thromboembolism and its role in expanding the differential diagnosis of heparin-induced thrombocytopenia. Am J Hematol. 2004;76(1):69-73. https://doi.org/10.1002/ajh.20009